Canopy Growth Corp
TSX:WEED

Watchlist Manager
Canopy Growth Corp Logo
Canopy Growth Corp
TSX:WEED
Watchlist
Price: 1.65 CAD -4.07%
Market Cap: 346.7m CAD

EV/EBIT
Enterprise Value to EBIT

-6.4
Current
-9.7
Median
15.7
Industry
Higher than median
Lower than industry value

Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT
-6.4
=
Enterprise Value
535.6m CAD
/
EBIT
-83.9m CAD
EBIT Growth EV/EBIT to Growth
CA
Canopy Growth Corp
TSX:WEED
Average EV/EBIT: 1 867
Negative Multiple: -6.4
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
38.7
32%
1.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
15.9
13%
1.2
DK
Novo Nordisk A/S
CSE:NOVO B
15.1
14%
1.1
CH
Roche Holding AG
SIX:ROG
11
6%
1.8
CH
Novartis AG
SIX:NOVN
14
10%
1.4
UK
AstraZeneca PLC
LSE:AZN
197
23%
8.6
US
Merck & Co Inc
NYSE:MRK
10.3
11%
0.9
IE
E
Endo International PLC
LSE:0Y5F
655.3
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.5
10%
1

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBIT
-7.4
2-Years Forward
EV/EBIT
-10.5
3-Years Forward
EV/EBIT
-13.8